Author
Mayo Clinic
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
3 papers
Recent·Most cited
John Michael Replogle, Jordan D. Marks, Martin G. Fernandez…·Michael Emmerson Ward
The paper identifies TMEM106B fibril accumulation as a shared mechanism in neurodegeneration linked to genetic variants in TMEM106B and GRN.
James T. O’Connor, Hui Qi Loo, Caiwei Guo…·Aaron DiAntonio
This study identifies ATP8A2 as a TDP-43 target whose loss leads to PS exposure and neuroinflammation, suggesting immune cell inhibition as a therapeutic strategy for ALS-FTD and CAMRQ4.
Yi Zeng, Anastasiia Lovchykova, Tetsuya Akiyama…·Aaron D. Gitler
This study shows that TDP-43 nuclear loss in FTD/ALS causes widespread alternative polyadenylation changes affecting disease-relevant genes.